Google Übersetzer
Replimune Group, Inc.
About
Replimune Group, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 10 2026
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
Feb 3 2026
Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
Dec 18 2025
Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference
Nov 7 2025
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)
Recent Videos
Replimune’s chairman on FDA’s polarizing decision not to approve melanoma drug.
Apr 22, 2026
Replimune co-founder calls FDA rejection of melanoma drug ‘unfair’
Apr 13, 2026
Biotech Semanal: Cue, Zentalis y Estrella (+100%) y el drama de Replimune.
Apr 13, 2026
FDA Rejects Replimune's Melanoma Drug Again, and the Company May Walk Away | The Week Ahead
Apr 13, 2026